RNA epigenetics and cardiovascular diseases

Area of Science:

• Molecular Biology
• Cardiovascular Science
• Epigenetics

Background:

• Cardiovascular disease (CVD) is a leading cause of mortality globally.
• The role of RNA epigenetics in cardiovascular health and disease is an emerging area of research.
• RNA modifications represent a novel layer of gene regulation impacting RNA metabolism and gene expression.

Purpose of the Study:

• To review recent advancements in RNA methylation and adenosine to inosine (A-to-I) RNA editing within the cardiovascular field.
• To explore the potential of RNA modifications in understanding CVD pathogenesis.
• To discuss the implications of these findings for developing precision medicine strategies in cardiology.

Main Methods:

• Literature review of recent studies on RNA modifications in cardiovascular contexts.
• Focus on RNA methylation and A-to-I RNA editing.
• Analysis of their roles in gene regulation and disease mechanisms.

Main Results:

• RNA modifications provide a new regulatory layer influencing gene expression post-transcriptionally.
• Emerging evidence links specific RNA modifications to cardiovascular functions and disease.
• RNA editing, particularly A-to-I, is increasingly recognized for its impact on cardiovascular biology.

Conclusions:

• Understanding RNA modifications is crucial for deciphering complex CVD mechanisms.
• RNA methylation and editing hold promise for the development of innovative biomarkers.
• This field is advancing cardiovascular precision medicine through novel therapeutic targets.